Skip to main content

Table 1 Characteristics of PDAC patients in IHC analysis for stromal C4BPA expression

From: C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocytes in the tumor microenvironment in pancreatic cancer

 

C4BPA expression

P value

High (n=96)

Low (n=75)

Age (y.o. mean ± SD)

65.7±9.3

65.9±10.4

0.87

Gender (male/female)

51/45

48/27

0.15

Tumor location (head/body-tail)

67/30

56/19

0.50

Tumor volume (mm3 median (IQR))

6462 (4450,13124)

6283 (4450,13124)

0.18

UICC

 pT stage (pT3,4/pT1,2)

95/1

72/3

0.20

 pN stage (pN1,2,3/pN0)

74/22

54/21

0.45

 Curability (R1,2/R0)

36/60

34/41

0.30

Perioperative therapy

 Neoadjuvant therapy (+/−)

36/60

38/37

0.84

 Adjuvant chemotherapy (+/−)

85/11

61/14

0.19

Recurrence site

 Local recurrence (+/−)

36/60

31/44

0.61

 Hematogenous recurrence (+/−)

49/47

48/27

0.088

  1. (chi-square test).
  2. SD Standard deviation, IQR Interquartile range, p Pathological findings, T Primary tumor, N Regional lymph nodes